Determination of Serum Unbound Bilirubin for Prediction of Kernicterus in Low Birthweight infants
Tóm tắt
Serum unbound bilirubin concentrations (UBC) and serum total bilirubin concentrations (TBC) were measured serially in 138 low birthweight (LBW) infants treated with phototherapy for non‐hemolytic hyperbilirubinemia. We attempted to assign the suitable critical UBC levels for predicting bilirubin encephalopathy into two different birthweight groups: a very low birthweight (VLBW) group (birthweight < 1,500 g) and an LBW group (birthweight between 1,500 g and 2,499 g). Twelve infants were diagnosed as ‘at risk’ for kernicterus, of whom 11 had signs of acute bilirubin encephalopathy and exchange transfusion. One VLBW infant had neurological sequelae at a 3 year follow‐up, although exchange transfusion was not carried out because of low TBC.
Sensitivity and specificity for predicting kernicterus were calculated at different UBC levels between 0.6μg/dl and 1.5μg/dl and TBC levels between 8 mg/dl and 26 mg/dl. The receiver‐operating characteristic (ROC) curves plotted for UBC as a predictor of kernicterus were clearly shifted up and to the left compared with the curves for TBC in the VLBW and LBW groups. Thus, the UBC measurement may well provide a more rational basis for evaluating the risk of kernicterus in LBW infants. The optimal cut‐off points were derived from these curves. In the VLBW group, the sensitivity was 100% and the specificity was 96% for a UBC of 0.8μg/dl, and 80% and 64% for a TBC of 11 mg/dl. In the LBW group, the sensitivity was 100% and the specificity was 98% for a UBC of 1.0μg/dl and 71% and 78% for a TBC of 16 mg/dl. These results suggest that UBC determination is more suitable for predicting kernicterus than TBC in LBW infants with non‐hemolytic hyperbilirubinemia.
Từ khóa
Tài liệu tham khảo
Gartner LM, 1970, Kernicterus: High incidence in premature infants with low serum bilirubin concentrations, Pediatrics, 45, 906, 10.1542/peds.45.6.906
Turkel SB, 1980, Lack of identifiable risk factors for kernicterus, Pediatrics, 66, 502, 10.1542/peds.66.4.502
Lipsitz PJ, 1985, Neonatal and infant mortality in relation to phototherapy, Pediatrics, 75, 422, 10.1542/peds.75.2.422
Zamet P., 1976, Bilirubin Metabolism in the Newborn, 236
Cashore WJ, 1982, Unbound bilirubin and kernicterus in low‐birth weight infants, Pediatrics, 69, 481, 10.1542/peds.69.4.481
Valaes T., 1976, Bilirubin Metabolism in the Newborn, 215
Brown AK, 1980, A rapid fluorometric method for determining bilirubin levels and binding in the blood of neonates: Comparisons with a diazo method and with 2‐(4′‐hydroxybenzene) azobenzoic acid dye binding, Pediatrics, 65, 767, 10.1542/peds.65.4.767
Nakamura H., 1985, Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia, Pediatrics, 75, 703, 10.1542/peds.75.4.703
Shimabuku R., 1982, Total and unbound bilirubin determination using an automated peroxidase micromethod, Kobe J Med Sci, 28, 91
Bratlid D., 1984, Effect of acidosis on bilirubin deposition in rat brain, Pediatrics, 73, 431, 10.1542/peds.73.4.431
Brodersen R., 1979, Bilirubin solubility and interaction with albumin and phospholipid, J Biol Chem, 254, 2364, 10.1016/S0021-9258(17)30230-2
Perlman M., 1988, Bilirubin beyond the blood‐brain barrier, Pediatrics, 81, 304
Wennberg RP, 1990, Experimental bilirubin encephalopathy: Role of the blood‐brain barrier, Fern-strom Found Ser, 14, 269
Praagh X., 1961, Diagnosis of kernicterus in the neonatal period, Pediatrics, 28, 870, 10.1542/peds.28.6.870
Bor M., 1989, Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: Results of a national collaborative study, Pediatrics, 83, 915, 10.1542/peds.83.6.915
Bor M., 1990, Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 5 years of age, Pediatr Res, 27, 259A